RespireRx Pharmaceuticals Inc Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
RespireRx Pharmaceuticals Inc Announces that Jeff Margolis, the Company s CFO is presenting at the Investor Summit Q4 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
HIGHLIGHTS (1) ATTRIBUTABLE & ADJUSTED ATTRIBUTABLE THIRD QUARTER DILUTED EPS OF $(0.12) AND $(0.07) PER SHARE, RESPECTIVELY QUARTERLY PRODUCTION OF 106,919.